Evidence map›Paper›PMID 37515641›Full record

ArticleInternational urogynecology journal2023

Urethral Bulkamid® injection after failed midurethral sling: a step-by-step video.

David Lukanović, Mija Blaganje, Inas Rhazi, Bruno Deval

Abstract readVideo-Audio MediaCase Reports
PubMed Publisher
In one paragraph

Article in International urogynecology journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

David Lukanović *Department of Gynecology, Division of Gynecology and Obstetrics, University Medical Center Ljubljana, Ljubljana, Slovenia.
Mija Blaganje *Department of Gynecology, Division of Gynecology and Obstetrics, University Medical Center Ljubljana, Ljubljana, Slovenia. mija.blaganje@kclj.si.ORCID 0000-0002-3354-2581
Inas RhaziDepartment of Functional Pelvic Surgery and Oncology, Geoffroy Saint-Hilaire, Ramsay, Générale de Santé, Paris, France.
Bruno DevalDepartment of Functional Pelvic Surgery and Oncology, Geoffroy Saint-Hilaire, Ramsay, Générale de Santé, Paris, France.
University of Ljubljana · SIGénérale de Santé · FRMohamed I University · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction and hypothesisBulking agents are a minimally invasive treatment option for women with stress urinary incontinence (SUI) or stress-predominant mixed urinary incontinence (MUI). Recurrent SUI is a major challenge for most clinicians because there is little evidence in the literature on the best option after midurethral sling (MUS) failure.

methodsBulkamid® (Contura International A/S), a urethral bulking agent, is a homogenous gel without particles, consisting of a polyacrylamide hydrogel that is nonbiodegradable.

resultsIn this video case report, we demonstrate the Bulkamid® injection procedure. This procedure can be carried out as an office-based procedure under local anesthesia, with no down time and only minor possible complications.

conclusionsWe consider it a valid option for patients with recurrent or persistent SUI after failed MUS surgery.

Indexed as

Suburethral SlingsUrinary Incontinence, StressAcrylic ResinsFemaleHumansHydrogelsTreatment OutcomeUrethraAcrylic ResinsBulkamidHydrogelsBulkamid®Midurethral slingStress urinary incontinenceUrethral bulking agents

Identifiers

PMID37515641
OpenAlexW4385368784

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.